TECTONIC THERAPEUTIC, INC. Fair Value Adjustment of Warrants
TECTONIC THERAPEUTIC, INC. (TECX) reported Fair Value Adjustment of Warrants of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-03-16
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for the quarter ending 2019-09-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for the quarter ending 2018-06-30 was $150.00K.
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for fiscal 2018 was $162.00K, a 852.94% increase from fiscal 2017.
- TECTONIC THERAPEUTIC, INC. fair value adjustment of warrants for fiscal 2017 was $17.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $150.00K derived: sum of 3 quarters · filed 2020-03-16 | $162.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-07 | $150.00K derived: sum of 2 quarters · filed 2019-08-08 | $162.00K 10-Q · filed 2019-11-07 | $173.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $150.00K 10-Q · filed 2019-08-08 | $162.00K 10-Q · filed 2019-08-08 | $173.00K derived: sum of 3 quarters · filed 2019-08-08 | $179.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $12.00K 10-Q · filed 2019-05-13 | $23.00K derived: sum of 2 quarters · filed 2019-05-13 | $29.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $17.00K derived: sum of 2 quarters · filed 2019-03-25 | $17.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | $6.00K 10-Q · filed 2018-11-13 | $6.00K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |